产品中心 抗体 Biosimilar抗体

所有图片(1/1)

Anti-TNFRSF17/CD269/BCMA/TNFRSF13A Monoclonal Antibody (Belantamab)

价格 2,600.00 供应商现货 : 3-5个工作日
货号 S0E0031
规格
数量
收藏 分享

产品介绍 评论(0)

产品规格
  • 宿主来源

    Human
  • 克隆号

    S-SC040
  • 抗体类型

    Recombinant mAb
  • 抗体同种型

    IgG1,k
  • 反应种属 ?

    Hu
  • 纯化方式

    Protein A
  • 浓度

    5 mg/ml
  • 内毒素含量

    <1EU/mg
  • 标记

    Unconjugated
  • 性状

    Liquid
  • 缓冲体系

    PBS pH7.4, containing no preservative

  • 储存条件

    2 to 8 °C for 2 weeks under sterile conditions;
    -20 °C for 3 months under sterile conditions;
    -80 °C for 24 months under sterile conditions.
    Please avoid repeated freeze-thaw cycles.

  • 应用

    Blocking of TNFRSF17/CD269/BCMA/TNFRSF13A signaling Functional assays

背景介绍
  • Belantamab is an antibody-drug conjugate targeting B-cell maturation antigen (BCMA), specifically designed for the treatment of relapsed or refractory multiple myeloma. The drug is composed of a humanized monoclonal antibody that specifically binds to BCMA, a stable linker, and the potent cytotoxic agent monomethyl auristatin F (MMAF), which precisely delivers the toxin into myeloma cells. It kills cancer cells by disrupting microtubule structure and inducing immune responses.

  • ELISA

    • Immobilized BCMA/TNFRSF17 His Tag Protein, Human(UA010083) can bind Belantamab. The EC50 for this effect is 2.062 ng/mL.

评论(0)